Company Filing History:
Years Active: 2025
Title: Kevin McGowan: Innovator in Pharmaceutical Research
Introduction
Kevin McGowan is a notable inventor based in Memphis, TN (US). He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that modulate protein activity. With a total of 2 patents, his work is focused on addressing critical clinical conditions.
Latest Patents
Kevin's latest patents include the development of substituted N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)arylsulfonamide analogs. These compounds are designed as modulators of cereblon protein activity. The disclosure outlines methods for creating these compounds, their pharmaceutical compositions, and their potential applications in treating disorders related to uncontrolled cellular proliferation, such as cancer. The compounds can selectively modulate the degradation of GSPT1 protein, acting as GSPT1 degraders.
Career Highlights
Kevin McGowan is affiliated with St. Jude Children's Research Hospital, where he contributes to groundbreaking research in the pharmaceutical field. His work is instrumental in developing innovative solutions for complex medical challenges.
Collaborations
Some of Kevin's coworkers include Fatemeh Keramatnia and Jaeki Min, who collaborate with him on various research projects.
Conclusion
Kevin McGowan's innovative work in pharmaceutical research highlights his commitment to advancing medical science. His contributions through patents and collaborations are paving the way for new treatments and therapies.